nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Tacrolimus—atopic dermatitis	0.102	0.231	CbGbCtD
Carfilzomib—ABCB1—Loratadine—atopic dermatitis	0.075	0.169	CbGbCtD
Carfilzomib—ABCB1—Methylprednisolone—atopic dermatitis	0.0686	0.155	CbGbCtD
Carfilzomib—ABCB1—Betamethasone—atopic dermatitis	0.0446	0.1	CbGbCtD
Carfilzomib—ABCB1—Prednisolone—atopic dermatitis	0.044	0.0991	CbGbCtD
Carfilzomib—ABCB1—Hydrocortisone—atopic dermatitis	0.0417	0.094	CbGbCtD
Carfilzomib—ABCB1—Prednisone—atopic dermatitis	0.0415	0.0936	CbGbCtD
Carfilzomib—ABCB1—Dexamethasone—atopic dermatitis	0.0259	0.0584	CbGbCtD
Carfilzomib—PSMB2—skin epidermis—atopic dermatitis	0.0132	0.403	CbGeAlD
Carfilzomib—PSMB10—head—atopic dermatitis	0.00548	0.168	CbGeAlD
Carfilzomib—PSMB1—skin of body—atopic dermatitis	0.00418	0.128	CbGeAlD
Carfilzomib—PSMB2—skin of body—atopic dermatitis	0.00407	0.125	CbGeAlD
Carfilzomib—PSMB1—head—atopic dermatitis	0.00272	0.0834	CbGeAlD
Carfilzomib—PSMB2—head—atopic dermatitis	0.00266	0.0814	CbGeAlD
Carfilzomib—PSMB5—Everolimus—Tacrolimus—atopic dermatitis	0.00252	0.129	CbGdCrCtD
Carfilzomib—PSMB5—Everolimus—Pimecrolimus—atopic dermatitis	0.00252	0.129	CbGdCrCtD
Carfilzomib—PSMB8—Tacrolimus—Pimecrolimus—atopic dermatitis	0.00203	0.104	CbGdCrCtD
Carfilzomib—Infection—Pimecrolimus—atopic dermatitis	0.00146	0.00451	CcSEcCtD
Carfilzomib—Anorexia—Diphenhydramine—atopic dermatitis	0.00145	0.00447	CcSEcCtD
Carfilzomib—Anorexia—Dimenhydrinate—atopic dermatitis	0.00145	0.00447	CcSEcCtD
Carfilzomib—Pain—Fluocinonide—atopic dermatitis	0.00144	0.00445	CcSEcCtD
Carfilzomib—Neuritis—Prednisone—atopic dermatitis	0.00139	0.0043	CcSEcCtD
Carfilzomib—Insomnia—Dimenhydrinate—atopic dermatitis	0.00137	0.00425	CcSEcCtD
Carfilzomib—Insomnia—Diphenhydramine—atopic dermatitis	0.00137	0.00425	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Pimecrolimus—atopic dermatitis	0.00134	0.00414	CcSEcCtD
Carfilzomib—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.00132	0.00408	CcSEcCtD
Carfilzomib—Decreased appetite—Diphenhydramine—atopic dermatitis	0.00132	0.00408	CcSEcCtD
Carfilzomib—Neutropenia—Tacrolimus—atopic dermatitis	0.00131	0.00406	CcSEcCtD
Carfilzomib—Fatigue—Diphenhydramine—atopic dermatitis	0.00131	0.00405	CcSEcCtD
Carfilzomib—Fatigue—Dimenhydrinate—atopic dermatitis	0.00131	0.00405	CcSEcCtD
Carfilzomib—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00131	0.00405	CcSEcCtD
Carfilzomib—Headache—Desonide—atopic dermatitis	0.0013	0.00403	CcSEcCtD
Carfilzomib—Constipation—Diphenhydramine—atopic dermatitis	0.0013	0.00401	CcSEcCtD
Carfilzomib—Constipation—Dimenhydrinate—atopic dermatitis	0.0013	0.00401	CcSEcCtD
Carfilzomib—Hyperglycaemia—Tacrolimus—atopic dermatitis	0.00127	0.00392	CcSEcCtD
Carfilzomib—Pneumonia—Tacrolimus—atopic dermatitis	0.00126	0.00389	CcSEcCtD
Carfilzomib—Pain—Pimecrolimus—atopic dermatitis	0.00126	0.00388	CcSEcCtD
Carfilzomib—Constipation—Pimecrolimus—atopic dermatitis	0.00126	0.00388	CcSEcCtD
Carfilzomib—Cough—Loratadine—atopic dermatitis	0.00125	0.00387	CcSEcCtD
Carfilzomib—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.00125	0.00385	CcSEcCtD
Carfilzomib—Hypertension—Loratadine—atopic dermatitis	0.00124	0.00382	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Tacrolimus—atopic dermatitis	0.00123	0.00382	CcSEcCtD
Carfilzomib—Renal failure—Tacrolimus—atopic dermatitis	0.00123	0.00381	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Tacrolimus—atopic dermatitis	0.00123	0.0038	CcSEcCtD
Carfilzomib—Back pain—Mometasone—atopic dermatitis	0.00119	0.00368	CcSEcCtD
Carfilzomib—Body temperature increased—Pimecrolimus—atopic dermatitis	0.00116	0.00359	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisolone—atopic dermatitis	0.00114	0.00354	CcSEcCtD
Carfilzomib—Cough—Fluocinolone Acetonide—atopic dermatitis	0.00112	0.00347	CcSEcCtD
Carfilzomib—Hypoaesthesia—Tacrolimus—atopic dermatitis	0.00112	0.00346	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Hydrocortisone—atopic dermatitis	0.00112	0.00346	CcSEcCtD
Carfilzomib—Dizziness—Fluocinonide—atopic dermatitis	0.00111	0.00344	CcSEcCtD
Carfilzomib—Oedema peripheral—Tacrolimus—atopic dermatitis	0.00111	0.00342	CcSEcCtD
Carfilzomib—Arthralgia—Fluocinolone Acetonide—atopic dermatitis	0.0011	0.00339	CcSEcCtD
Carfilzomib—Asthenia—Diphenhydramine—atopic dermatitis	0.00109	0.00337	CcSEcCtD
Carfilzomib—Asthenia—Dimenhydrinate—atopic dermatitis	0.00109	0.00337	CcSEcCtD
Carfilzomib—Cough—Mometasone—atopic dermatitis	0.00107	0.00332	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.00107	0.00329	CcSEcCtD
Carfilzomib—Insomnia—Loratadine—atopic dermatitis	0.00106	0.00327	CcSEcCtD
Carfilzomib—Headache—Fluocinonide—atopic dermatitis	0.00105	0.00326	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Triamcinolone—atopic dermatitis	0.00105	0.00325	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Methylprednisolone—atopic dermatitis	0.00105	0.00325	CcSEcCtD
Carfilzomib—Arthralgia—Mometasone—atopic dermatitis	0.00105	0.00324	CcSEcCtD
Carfilzomib—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00104	0.00323	CcSEcCtD
Carfilzomib—Cardiac disorder—Tacrolimus—atopic dermatitis	0.00104	0.00323	CcSEcCtD
Carfilzomib—Diarrhoea—Diphenhydramine—atopic dermatitis	0.00104	0.00321	CcSEcCtD
Carfilzomib—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.00104	0.00321	CcSEcCtD
Carfilzomib—Chills—Tacrolimus—atopic dermatitis	0.00101	0.00312	CcSEcCtD
Carfilzomib—Fatigue—Loratadine—atopic dermatitis	0.00101	0.00312	CcSEcCtD
Carfilzomib—Diarrhoea—Pimecrolimus—atopic dermatitis	0.001	0.00311	CcSEcCtD
Carfilzomib—Dizziness—Diphenhydramine—atopic dermatitis	0.001	0.0031	CcSEcCtD
Carfilzomib—Dizziness—Dimenhydrinate—atopic dermatitis	0.001	0.0031	CcSEcCtD
Carfilzomib—Constipation—Loratadine—atopic dermatitis	0.001	0.00309	CcSEcCtD
Carfilzomib—Pain—Loratadine—atopic dermatitis	0.001	0.00309	CcSEcCtD
Carfilzomib—Infection—Mometasone—atopic dermatitis	0.000997	0.00308	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisolone—atopic dermatitis	0.000987	0.00305	CcSEcCtD
Carfilzomib—Vomiting—Dimenhydrinate—atopic dermatitis	0.000965	0.00298	CcSEcCtD
Carfilzomib—Vomiting—Diphenhydramine—atopic dermatitis	0.000965	0.00298	CcSEcCtD
Carfilzomib—Cardiac arrest—Hydrocortisone—atopic dermatitis	0.000964	0.00298	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000957	0.00296	CcSEcCtD
Carfilzomib—Anorexia—Mometasone—atopic dermatitis	0.000956	0.00296	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Dexamethasone—atopic dermatitis	0.000955	0.00295	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Betamethasone—atopic dermatitis	0.000955	0.00295	CcSEcCtD
Carfilzomib—Headache—Dimenhydrinate—atopic dermatitis	0.000951	0.00294	CcSEcCtD
Carfilzomib—Headache—Diphenhydramine—atopic dermatitis	0.000951	0.00294	CcSEcCtD
Carfilzomib—Back pain—Tacrolimus—atopic dermatitis	0.000946	0.00293	CcSEcCtD
Carfilzomib—Muscle spasms—Tacrolimus—atopic dermatitis	0.000941	0.00291	CcSEcCtD
Carfilzomib—Vomiting—Pimecrolimus—atopic dermatitis	0.000933	0.00289	CcSEcCtD
Carfilzomib—Body temperature increased—Loratadine—atopic dermatitis	0.000924	0.00286	CcSEcCtD
Carfilzomib—Hypokalaemia—Hydrocortisone—atopic dermatitis	0.000922	0.00285	CcSEcCtD
Carfilzomib—Headache—Pimecrolimus—atopic dermatitis	0.000919	0.00284	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000914	0.00283	CcSEcCtD
Carfilzomib—Cardiac arrest—Triamcinolone—atopic dermatitis	0.000907	0.00281	CcSEcCtD
Carfilzomib—Cardiac arrest—Methylprednisolone—atopic dermatitis	0.000905	0.0028	CcSEcCtD
Carfilzomib—Anaemia—Tacrolimus—atopic dermatitis	0.000904	0.0028	CcSEcCtD
Carfilzomib—Nausea—Dimenhydrinate—atopic dermatitis	0.000902	0.00279	CcSEcCtD
Carfilzomib—Nausea—Diphenhydramine—atopic dermatitis	0.000902	0.00279	CcSEcCtD
Carfilzomib—Sepsis—Prednisone—atopic dermatitis	0.000901	0.00279	CcSEcCtD
Carfilzomib—Pain—Fluocinolone Acetonide—atopic dermatitis	0.000898	0.00278	CcSEcCtD
Carfilzomib—Dyspnoea—Mometasone—atopic dermatitis	0.000894	0.00277	CcSEcCtD
Carfilzomib—Leukopenia—Tacrolimus—atopic dermatitis	0.000876	0.00271	CcSEcCtD
Carfilzomib—Decreased appetite—Mometasone—atopic dermatitis	0.000872	0.0027	CcSEcCtD
Carfilzomib—Nausea—Pimecrolimus—atopic dermatitis	0.000872	0.0027	CcSEcCtD
Carfilzomib—Fatigue—Mometasone—atopic dermatitis	0.000865	0.00268	CcSEcCtD
Carfilzomib—Pain—Mometasone—atopic dermatitis	0.000858	0.00265	CcSEcCtD
Carfilzomib—Cough—Tacrolimus—atopic dermatitis	0.000854	0.00264	CcSEcCtD
Carfilzomib—Hypertension—Tacrolimus—atopic dermatitis	0.000845	0.00261	CcSEcCtD
Carfilzomib—Asthenia—Loratadine—atopic dermatitis	0.000839	0.00259	CcSEcCtD
Carfilzomib—Arthralgia—Tacrolimus—atopic dermatitis	0.000833	0.00258	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisone—atopic dermatitis	0.000831	0.00257	CcSEcCtD
Carfilzomib—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000831	0.00257	CcSEcCtD
Carfilzomib—Cardiac arrest—Betamethasone—atopic dermatitis	0.000823	0.00255	CcSEcCtD
Carfilzomib—Cardiac arrest—Dexamethasone—atopic dermatitis	0.000823	0.00255	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000814	0.00252	CcSEcCtD
Carfilzomib—Diarrhoea—Loratadine—atopic dermatitis	0.0008	0.00247	CcSEcCtD
Carfilzomib—Infection—Tacrolimus—atopic dermatitis	0.000793	0.00245	CcSEcCtD
Carfilzomib—Body temperature increased—Mometasone—atopic dermatitis	0.000793	0.00245	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisolone—atopic dermatitis	0.000788	0.00244	CcSEcCtD
Carfilzomib—Hypokalaemia—Dexamethasone—atopic dermatitis	0.000788	0.00244	CcSEcCtD
Carfilzomib—Hypokalaemia—Betamethasone—atopic dermatitis	0.000788	0.00244	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisolone—atopic dermatitis	0.000784	0.00242	CcSEcCtD
Carfilzomib—Thrombocytopenia—Tacrolimus—atopic dermatitis	0.000782	0.00242	CcSEcCtD
Carfilzomib—Dizziness—Loratadine—atopic dermatitis	0.000773	0.00239	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Hydrocortisone—atopic dermatitis	0.00077	0.00238	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000767	0.00237	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Hydrocortisone—atopic dermatitis	0.000766	0.00237	CcSEcCtD
Carfilzomib—Anorexia—Tacrolimus—atopic dermatitis	0.000761	0.00235	CcSEcCtD
Carfilzomib—Vomiting—Loratadine—atopic dermatitis	0.000743	0.0023	CcSEcCtD
Carfilzomib—Headache—Loratadine—atopic dermatitis	0.000732	0.00227	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000727	0.00225	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Triamcinolone—atopic dermatitis	0.000725	0.00224	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Methylprednisolone—atopic dermatitis	0.000723	0.00224	CcSEcCtD
Carfilzomib—Insomnia—Tacrolimus—atopic dermatitis	0.000722	0.00223	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Triamcinolone—atopic dermatitis	0.000721	0.00223	CcSEcCtD
Carfilzomib—Asthenia—Mometasone—atopic dermatitis	0.00072	0.00223	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Methylprednisolone—atopic dermatitis	0.000719	0.00222	CcSEcCtD
Carfilzomib—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000719	0.00222	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisone—atopic dermatitis	0.000717	0.00222	CcSEcCtD
Carfilzomib—Dyspnoea—Tacrolimus—atopic dermatitis	0.000712	0.0022	CcSEcCtD
Carfilzomib—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000695	0.00215	CcSEcCtD
Carfilzomib—Nausea—Loratadine—atopic dermatitis	0.000694	0.00215	CcSEcCtD
Carfilzomib—Decreased appetite—Tacrolimus—atopic dermatitis	0.000694	0.00215	CcSEcCtD
Carfilzomib—Fatigue—Tacrolimus—atopic dermatitis	0.000688	0.00213	CcSEcCtD
Carfilzomib—Diarrhoea—Mometasone—atopic dermatitis	0.000686	0.00212	CcSEcCtD
Carfilzomib—Hypokalaemia—Prednisone—atopic dermatitis	0.000686	0.00212	CcSEcCtD
Carfilzomib—Pain—Tacrolimus—atopic dermatitis	0.000683	0.00211	CcSEcCtD
Carfilzomib—Constipation—Tacrolimus—atopic dermatitis	0.000683	0.00211	CcSEcCtD
Carfilzomib—Hyperglycaemia—Betamethasone—atopic dermatitis	0.000675	0.00209	CcSEcCtD
Carfilzomib—Hyperglycaemia—Dexamethasone—atopic dermatitis	0.000675	0.00209	CcSEcCtD
Carfilzomib—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000668	0.00207	CcSEcCtD
Carfilzomib—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000658	0.00204	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Dexamethasone—atopic dermatitis	0.000658	0.00203	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Betamethasone—atopic dermatitis	0.000658	0.00203	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Dexamethasone—atopic dermatitis	0.000654	0.00202	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Betamethasone—atopic dermatitis	0.000654	0.00202	CcSEcCtD
Carfilzomib—Vomiting—Mometasone—atopic dermatitis	0.000638	0.00197	CcSEcCtD
Carfilzomib—Body temperature increased—Tacrolimus—atopic dermatitis	0.000631	0.00195	CcSEcCtD
Carfilzomib—Headache—Mometasone—atopic dermatitis	0.000628	0.00194	CcSEcCtD
Carfilzomib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000624	0.00193	CcSEcCtD
Carfilzomib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000611	0.00189	CcSEcCtD
Carfilzomib—Neutropenia—Prednisone—atopic dermatitis	0.000609	0.00188	CcSEcCtD
Carfilzomib—Nausea—Mometasone—atopic dermatitis	0.000596	0.00184	CcSEcCtD
Carfilzomib—Hyperglycaemia—Prednisone—atopic dermatitis	0.000588	0.00182	CcSEcCtD
Carfilzomib—PSMB8—Everolimus—Pimecrolimus—atopic dermatitis	0.000582	0.0297	CbGdCrCtD
Carfilzomib—PSMB8—Everolimus—Tacrolimus—atopic dermatitis	0.000582	0.0297	CbGdCrCtD
Carfilzomib—Asthenia—Tacrolimus—atopic dermatitis	0.000573	0.00177	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000573	0.00177	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisone—atopic dermatitis	0.00057	0.00176	CcSEcCtD
Carfilzomib—Back pain—Triamcinolone—atopic dermatitis	0.000556	0.00172	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Desonide—atopic dermatitis	0.000552	0.0282	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Desonide—atopic dermatitis	0.000552	0.0282	CbGdCrCtD
Carfilzomib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000546	0.00169	CcSEcCtD
Carfilzomib—Hypertension—Prednisolone—atopic dermatitis	0.00054	0.00167	CcSEcCtD
Carfilzomib—Dizziness—Tacrolimus—atopic dermatitis	0.000528	0.00163	CcSEcCtD
Carfilzomib—Hypertension—Hydrocortisone—atopic dermatitis	0.000527	0.00163	CcSEcCtD
Carfilzomib—Vomiting—Tacrolimus—atopic dermatitis	0.000508	0.00157	CcSEcCtD
Carfilzomib—Cough—Triamcinolone—atopic dermatitis	0.000501	0.00155	CcSEcCtD
Carfilzomib—Headache—Tacrolimus—atopic dermatitis	0.0005	0.00155	CcSEcCtD
Carfilzomib—Hypertension—Triamcinolone—atopic dermatitis	0.000496	0.00153	CcSEcCtD
Carfilzomib—Hypertension—Methylprednisolone—atopic dermatitis	0.000495	0.00153	CcSEcCtD
Carfilzomib—Infection—Hydrocortisone—atopic dermatitis	0.000495	0.00153	CcSEcCtD
Carfilzomib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000488	0.00151	CcSEcCtD
Carfilzomib—Anorexia—Hydrocortisone—atopic dermatitis	0.000475	0.00147	CcSEcCtD
Carfilzomib—Nausea—Tacrolimus—atopic dermatitis	0.000474	0.00147	CcSEcCtD
Carfilzomib—Infection—Triamcinolone—atopic dermatitis	0.000466	0.00144	CcSEcCtD
Carfilzomib—Infection—Methylprednisolone—atopic dermatitis	0.000465	0.00144	CcSEcCtD
Carfilzomib—Insomnia—Prednisolone—atopic dermatitis	0.000461	0.00143	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000454	0.0014	CcSEcCtD
Carfilzomib—Insomnia—Hydrocortisone—atopic dermatitis	0.000451	0.00139	CcSEcCtD
Carfilzomib—Hypertension—Dexamethasone—atopic dermatitis	0.00045	0.00139	CcSEcCtD
Carfilzomib—Hypertension—Betamethasone—atopic dermatitis	0.00045	0.00139	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Fluocinonide—atopic dermatitis	0.000442	0.0226	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Fluocinonide—atopic dermatitis	0.000442	0.0226	CbGdCrCtD
Carfilzomib—Pain—Prednisolone—atopic dermatitis	0.000436	0.00135	CcSEcCtD
Carfilzomib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000433	0.00134	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.00043	0.022	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.00043	0.022	CbGdCrCtD
Carfilzomib—Fatigue—Hydrocortisone—atopic dermatitis	0.000429	0.00133	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000427	0.00132	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000426	0.00132	CcSEcCtD
Carfilzomib—Pain—Hydrocortisone—atopic dermatitis	0.000426	0.00132	CcSEcCtD
Carfilzomib—Insomnia—Triamcinolone—atopic dermatitis	0.000424	0.00131	CcSEcCtD
Carfilzomib—Insomnia—Methylprednisolone—atopic dermatitis	0.000423	0.00131	CcSEcCtD
Carfilzomib—Infection—Betamethasone—atopic dermatitis	0.000423	0.00131	CcSEcCtD
Carfilzomib—Infection—Dexamethasone—atopic dermatitis	0.000423	0.00131	CcSEcCtD
Carfilzomib—Anaemia—Prednisone—atopic dermatitis	0.00042	0.0013	CcSEcCtD
Carfilzomib—Dyspnoea—Triamcinolone—atopic dermatitis	0.000418	0.00129	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.000417	0.00129	CcSEcCtD
Carfilzomib—Thrombocytopenia—Betamethasone—atopic dermatitis	0.000417	0.00129	CcSEcCtD
Carfilzomib—ABCB1—head—atopic dermatitis	0.000406	0.0124	CbGeAlD
Carfilzomib—Anorexia—Dexamethasone—atopic dermatitis	0.000406	0.00125	CcSEcCtD
Carfilzomib—Anorexia—Betamethasone—atopic dermatitis	0.000406	0.00125	CcSEcCtD
Carfilzomib—Fatigue—Triamcinolone—atopic dermatitis	0.000404	0.00125	CcSEcCtD
Carfilzomib—Fatigue—Methylprednisolone—atopic dermatitis	0.000403	0.00125	CcSEcCtD
Carfilzomib—Pain—Triamcinolone—atopic dermatitis	0.000401	0.00124	CcSEcCtD
Carfilzomib—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000394	0.00122	CcSEcCtD
Carfilzomib—Hypertension—Prednisone—atopic dermatitis	0.000392	0.00121	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000388	0.0012	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000388	0.0012	CcSEcCtD
Carfilzomib—Arthralgia—Prednisone—atopic dermatitis	0.000387	0.0012	CcSEcCtD
Carfilzomib—Insomnia—Betamethasone—atopic dermatitis	0.000385	0.00119	CcSEcCtD
Carfilzomib—Insomnia—Dexamethasone—atopic dermatitis	0.000385	0.00119	CcSEcCtD
Carfilzomib—Body temperature increased—Triamcinolone—atopic dermatitis	0.000371	0.00115	CcSEcCtD
Carfilzomib—Decreased appetite—Betamethasone—atopic dermatitis	0.00037	0.00114	CcSEcCtD
Carfilzomib—Decreased appetite—Dexamethasone—atopic dermatitis	0.00037	0.00114	CcSEcCtD
Carfilzomib—Infection—Prednisone—atopic dermatitis	0.000368	0.00114	CcSEcCtD
Carfilzomib—Fatigue—Dexamethasone—atopic dermatitis	0.000367	0.00113	CcSEcCtD
Carfilzomib—Fatigue—Betamethasone—atopic dermatitis	0.000367	0.00113	CcSEcCtD
Carfilzomib—Pain—Dexamethasone—atopic dermatitis	0.000364	0.00113	CcSEcCtD
Carfilzomib—Pain—Betamethasone—atopic dermatitis	0.000364	0.00113	CcSEcCtD
Carfilzomib—Asthenia—Hydrocortisone—atopic dermatitis	0.000357	0.00111	CcSEcCtD
Carfilzomib—Anorexia—Prednisone—atopic dermatitis	0.000353	0.00109	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Mometasone—atopic dermatitis	0.000343	0.0175	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Mometasone—atopic dermatitis	0.000343	0.0175	CbGdCrCtD
Carfilzomib—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000341	0.00105	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000338	0.00104	CcSEcCtD
Carfilzomib—Dizziness—Prednisolone—atopic dermatitis	0.000337	0.00104	CcSEcCtD
Carfilzomib—Asthenia—Triamcinolone—atopic dermatitis	0.000337	0.00104	CcSEcCtD
Carfilzomib—Body temperature increased—Dexamethasone—atopic dermatitis	0.000336	0.00104	CcSEcCtD
Carfilzomib—Body temperature increased—Betamethasone—atopic dermatitis	0.000336	0.00104	CcSEcCtD
Carfilzomib—Asthenia—Methylprednisolone—atopic dermatitis	0.000336	0.00104	CcSEcCtD
Carfilzomib—Insomnia—Prednisone—atopic dermatitis	0.000335	0.00104	CcSEcCtD
Carfilzomib—Dizziness—Hydrocortisone—atopic dermatitis	0.000329	0.00102	CcSEcCtD
Carfilzomib—Decreased appetite—Prednisone—atopic dermatitis	0.000322	0.000996	CcSEcCtD
Carfilzomib—Diarrhoea—Methylprednisolone—atopic dermatitis	0.00032	0.00099	CcSEcCtD
Carfilzomib—Fatigue—Prednisone—atopic dermatitis	0.00032	0.000988	CcSEcCtD
Carfilzomib—Headache—Prednisolone—atopic dermatitis	0.00032	0.000988	CcSEcCtD
Carfilzomib—Constipation—Prednisone—atopic dermatitis	0.000317	0.00098	CcSEcCtD
Carfilzomib—Vomiting—Hydrocortisone—atopic dermatitis	0.000317	0.000979	CcSEcCtD
Carfilzomib—PSMB10—Tamoxifen—Diphenhydramine—atopic dermatitis	0.000314	0.016	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Desonide—atopic dermatitis	0.000312	0.016	CbGdCrCtD
Carfilzomib—Headache—Hydrocortisone—atopic dermatitis	0.000312	0.000965	CcSEcCtD
Carfilzomib—Dizziness—Triamcinolone—atopic dermatitis	0.00031	0.000959	CcSEcCtD
Carfilzomib—Dizziness—Methylprednisolone—atopic dermatitis	0.000309	0.000957	CcSEcCtD
Carfilzomib—Asthenia—Dexamethasone—atopic dermatitis	0.000305	0.000944	CcSEcCtD
Carfilzomib—Asthenia—Betamethasone—atopic dermatitis	0.000305	0.000944	CcSEcCtD
Carfilzomib—Nausea—Prednisolone—atopic dermatitis	0.000303	0.000937	CcSEcCtD
Carfilzomib—Vomiting—Triamcinolone—atopic dermatitis	0.000298	0.000922	CcSEcCtD
Carfilzomib—Vomiting—Methylprednisolone—atopic dermatitis	0.000298	0.00092	CcSEcCtD
Carfilzomib—Nausea—Hydrocortisone—atopic dermatitis	0.000296	0.000915	CcSEcCtD
Carfilzomib—Headache—Triamcinolone—atopic dermatitis	0.000294	0.000909	CcSEcCtD
Carfilzomib—Headache—Methylprednisolone—atopic dermatitis	0.000293	0.000907	CcSEcCtD
Carfilzomib—Body temperature increased—Prednisone—atopic dermatitis	0.000293	0.000906	CcSEcCtD
Carfilzomib—Diarrhoea—Dexamethasone—atopic dermatitis	0.000291	0.000901	CcSEcCtD
Carfilzomib—Diarrhoea—Betamethasone—atopic dermatitis	0.000291	0.000901	CcSEcCtD
Carfilzomib—Dizziness—Dexamethasone—atopic dermatitis	0.000281	0.00087	CcSEcCtD
Carfilzomib—Dizziness—Betamethasone—atopic dermatitis	0.000281	0.00087	CcSEcCtD
Carfilzomib—Nausea—Triamcinolone—atopic dermatitis	0.000279	0.000862	CcSEcCtD
Carfilzomib—Nausea—Methylprednisolone—atopic dermatitis	0.000278	0.00086	CcSEcCtD
Carfilzomib—Vomiting—Dexamethasone—atopic dermatitis	0.000271	0.000837	CcSEcCtD
Carfilzomib—Vomiting—Betamethasone—atopic dermatitis	0.000271	0.000837	CcSEcCtD
Carfilzomib—Headache—Betamethasone—atopic dermatitis	0.000267	0.000825	CcSEcCtD
Carfilzomib—Headache—Dexamethasone—atopic dermatitis	0.000267	0.000825	CcSEcCtD
Carfilzomib—Asthenia—Prednisone—atopic dermatitis	0.000266	0.000822	CcSEcCtD
Carfilzomib—Diarrhoea—Prednisone—atopic dermatitis	0.000254	0.000784	CcSEcCtD
Carfilzomib—Nausea—Dexamethasone—atopic dermatitis	0.000253	0.000782	CcSEcCtD
Carfilzomib—Nausea—Betamethasone—atopic dermatitis	0.000253	0.000782	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Fluocinonide—atopic dermatitis	0.00025	0.0128	CbGdCrCtD
Carfilzomib—Dizziness—Prednisone—atopic dermatitis	0.000245	0.000758	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Fluocinolone Acetonide—atopic dermatitis	0.000243	0.0124	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Desonide—atopic dermatitis	0.000238	0.0122	CbGdCrCtD
Carfilzomib—Vomiting—Prednisone—atopic dermatitis	0.000236	0.000729	CcSEcCtD
Carfilzomib—Headache—Prednisone—atopic dermatitis	0.000232	0.000718	CcSEcCtD
Carfilzomib—Nausea—Prednisone—atopic dermatitis	0.00022	0.000681	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Hydrocortisone—atopic dermatitis	0.000217	0.0111	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000217	0.0111	CbGdCrCtD
Carfilzomib—PSMB2—Disease—SLC11A1—atopic dermatitis	0.000208	0.00115	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—SLC11A1—atopic dermatitis	0.000208	0.00115	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—SLC11A1—atopic dermatitis	0.000208	0.00115	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD8A—atopic dermatitis	0.000205	0.00114	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD8A—atopic dermatitis	0.000205	0.00114	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD8A—atopic dermatitis	0.000205	0.00114	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—SLC11A1—atopic dermatitis	0.000205	0.00113	CbGpPWpGaD
Carfilzomib—PSMB9—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000205	0.0105	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Methylprednisolone—atopic dermatitis	0.000205	0.0105	CbGdCrCtD
Carfilzomib—PSMB1—Signaling Pathways—CCL17—atopic dermatitis	0.000204	0.00113	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL17—atopic dermatitis	0.000204	0.00113	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL17—atopic dermatitis	0.000204	0.00113	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—STAT6—atopic dermatitis	0.000204	0.00113	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD79A—atopic dermatitis	0.000204	0.00113	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—STAT6—atopic dermatitis	0.000203	0.00113	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD79A—atopic dermatitis	0.000203	0.00112	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD8A—atopic dermatitis	0.000202	0.00112	CbGpPWpGaD
Carfilzomib—PSMB9—Dexamethasone—Betamethasone—atopic dermatitis	0.000202	0.0103	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Dexamethasone—atopic dermatitis	0.000202	0.0103	CbGdCrCtD
Carfilzomib—PSMB8—Signaling Pathways—CCL17—atopic dermatitis	0.000201	0.00111	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL1B—atopic dermatitis	0.000199	0.0011	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL2—atopic dermatitis	0.000198	0.0011	CbGpPWpGaD
Carfilzomib—PSMB9—Betamethasone—Triamcinolone—atopic dermatitis	0.000197	0.0101	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Triamcinolone—atopic dermatitis	0.000197	0.0101	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Mometasone—atopic dermatitis	0.000194	0.00991	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Fluocinonide—atopic dermatitis	0.00019	0.00973	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisone—atopic dermatitis	0.000187	0.00955	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisone—atopic dermatitis	0.000187	0.00955	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Fluocinolone Acetonide—atopic dermatitis	0.000185	0.00946	CbGdCrCtD
Carfilzomib—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	0.000183	0.00101	CbGpPWpGaD
Carfilzomib—PSMB9—Betamethasone—Prednisolone—atopic dermatitis	0.000182	0.00932	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisolone—atopic dermatitis	0.000182	0.00932	CbGdCrCtD
Carfilzomib—PSMB5—Signaling Pathways—KIF3A—atopic dermatitis	0.000182	0.00101	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—KIF3A—atopic dermatitis	0.000182	0.00101	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—KIF3A—atopic dermatitis	0.000182	0.00101	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CASP1—atopic dermatitis	0.000182	0.001	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CASP1—atopic dermatitis	0.000182	0.001	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CASP1—atopic dermatitis	0.000182	0.001	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—KIF3A—atopic dermatitis	0.00018	0.000994	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CASP1—atopic dermatitis	0.000179	0.00099	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCR3—atopic dermatitis	0.000177	0.00098	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCR3—atopic dermatitis	0.000176	0.000976	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL5—atopic dermatitis	0.000172	0.000952	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL5—atopic dermatitis	0.000172	0.000952	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL5—atopic dermatitis	0.000172	0.000952	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	0.000171	0.000944	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL5—atopic dermatitis	0.00017	0.000939	CbGpPWpGaD
Carfilzomib—PSMB8—Medrysone—Hydrocortisone—atopic dermatitis	0.00017	0.00866	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—IL18—atopic dermatitis	0.000167	0.000922	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL18—atopic dermatitis	0.000166	0.000918	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CMA1—atopic dermatitis	0.000165	0.000912	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL11—atopic dermatitis	0.000165	0.000912	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CMA1—atopic dermatitis	0.000165	0.000912	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL11—atopic dermatitis	0.000165	0.000912	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL11—atopic dermatitis	0.000165	0.000912	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CMA1—atopic dermatitis	0.000165	0.000912	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TLR2—atopic dermatitis	0.000164	0.000909	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TLR2—atopic dermatitis	0.000164	0.000909	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TLR2—atopic dermatitis	0.000164	0.000909	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD8A—atopic dermatitis	0.000164	0.000909	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	0.000164	0.000905	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD8A—atopic dermatitis	0.000163	0.000904	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL2—atopic dermatitis	0.000163	0.000902	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CMA1—atopic dermatitis	0.000162	0.000899	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCL11—atopic dermatitis	0.000162	0.000899	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TLR2—atopic dermatitis	0.000162	0.000896	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000161	0.000892	CbGpPWpGaD
Carfilzomib—PSMB8—Medrysone—Methylprednisolone—atopic dermatitis	0.00016	0.00817	CbGdCrCtD
Carfilzomib—PSMB5—Adaptive Immune System—NFKBIA—atopic dermatitis	0.000159	0.00088	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—NFKBIA—atopic dermatitis	0.000159	0.00088	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—NFKBIA—atopic dermatitis	0.000159	0.00088	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NPS—atopic dermatitis	0.000158	0.000874	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TAC1—atopic dermatitis	0.000158	0.000874	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NPS—atopic dermatitis	0.000157	0.00087	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TAC1—atopic dermatitis	0.000157	0.00087	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—NFKBIA—atopic dermatitis	0.000157	0.000868	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD4—atopic dermatitis	0.000155	0.00086	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—STAT6—atopic dermatitis	0.000155	0.000857	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—STAT6—atopic dermatitis	0.000155	0.000857	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—STAT6—atopic dermatitis	0.000155	0.000857	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCR3—atopic dermatitis	0.000155	0.000857	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD4—atopic dermatitis	0.000155	0.000856	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD79A—atopic dermatitis	0.000154	0.000854	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD79A—atopic dermatitis	0.000154	0.000854	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD79A—atopic dermatitis	0.000154	0.000854	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCR3—atopic dermatitis	0.000154	0.000853	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—STAT6—atopic dermatitis	0.000153	0.000845	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD79A—atopic dermatitis	0.000152	0.000842	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Mometasone—atopic dermatitis	0.000148	0.00755	CbGdCrCtD
Carfilzomib—PSMB10—Signaling Pathways—IL5—atopic dermatitis	0.000147	0.000812	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL5—atopic dermatitis	0.000146	0.000809	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—PPARA—atopic dermatitis	0.000143	0.000792	CbGpPWpGaD
Carfilzomib—PSMB8—Medrysone—Prednisolone—atopic dermatitis	0.000143	0.00728	CbGdCrCtD
Carfilzomib—PSMB9—Gene Expression—PPARA—atopic dermatitis	0.000142	0.000788	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CCR5—atopic dermatitis	0.000139	0.000767	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CCR5—atopic dermatitis	0.000138	0.000764	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR3—atopic dermatitis	0.000134	0.000743	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR3—atopic dermatitis	0.000134	0.000743	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR3—atopic dermatitis	0.000134	0.000743	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR3—atopic dermatitis	0.000132	0.000733	CbGpPWpGaD
Carfilzomib—PSMB8—Dexamethasone—Desonide—atopic dermatitis	0.000128	0.00652	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Desonide—atopic dermatitis	0.000128	0.00652	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—NFKBIA—atopic dermatitis	0.000127	0.000704	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—NFKBIA—atopic dermatitis	0.000127	0.000701	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL18—atopic dermatitis	0.000126	0.000699	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL18—atopic dermatitis	0.000126	0.000699	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL18—atopic dermatitis	0.000126	0.000699	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL10—atopic dermatitis	0.000125	0.000693	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL10—atopic dermatitis	0.000125	0.000689	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL18—atopic dermatitis	0.000125	0.000689	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD8A—atopic dermatitis	0.000124	0.000689	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD8A—atopic dermatitis	0.000124	0.000689	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD8A—atopic dermatitis	0.000124	0.000689	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Hydrocortisone—atopic dermatitis	0.000123	0.00627	CbGdCrCtD
Carfilzomib—PSMB8—Immune System—CD8A—atopic dermatitis	0.000123	0.000679	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TAC1—atopic dermatitis	0.00012	0.000662	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TAC1—atopic dermatitis	0.00012	0.000662	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TAC1—atopic dermatitis	0.00012	0.000662	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NPS—atopic dermatitis	0.00012	0.000662	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NPS—atopic dermatitis	0.00012	0.000662	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NPS—atopic dermatitis	0.00012	0.000662	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—atopic dermatitis	0.000119	0.000657	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.000118	0.000653	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TAC1—atopic dermatitis	0.000118	0.000653	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NPS—atopic dermatitis	0.000118	0.000653	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD4—atopic dermatitis	0.000118	0.000652	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD4—atopic dermatitis	0.000118	0.000652	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD4—atopic dermatitis	0.000118	0.000652	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCR3—atopic dermatitis	0.000117	0.00065	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCR3—atopic dermatitis	0.000117	0.00065	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCR3—atopic dermatitis	0.000117	0.00065	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—IL6—atopic dermatitis	0.000117	0.000646	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD4—atopic dermatitis	0.000116	0.000643	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Methylprednisolone—atopic dermatitis	0.000116	0.00592	CbGdCrCtD
Carfilzomib—PSMB8—Signaling Pathways—CXCR3—atopic dermatitis	0.000116	0.00064	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CASP8—atopic dermatitis	0.000115	0.000635	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CASP8—atopic dermatitis	0.000114	0.000632	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Dexamethasone—atopic dermatitis	0.000114	0.00582	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Betamethasone—atopic dermatitis	0.000114	0.00582	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Triamcinolone—atopic dermatitis	0.000111	0.00569	CbGdCrCtD
Carfilzomib—PSMB10—Metabolism—PPARA—atopic dermatitis	0.000111	0.000616	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL5—atopic dermatitis	0.000111	0.000616	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL5—atopic dermatitis	0.000111	0.000616	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL5—atopic dermatitis	0.000111	0.000616	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PPARA—atopic dermatitis	0.000111	0.000613	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL5—atopic dermatitis	0.00011	0.000607	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000109	0.000605	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—PPARA—atopic dermatitis	0.000108	0.0006	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—PPARA—atopic dermatitis	0.000108	0.0006	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—PPARA—atopic dermatitis	0.000108	0.0006	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCL5—atopic dermatitis	0.000108	0.000596	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCL5—atopic dermatitis	0.000107	0.000593	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—PPARA—atopic dermatitis	0.000107	0.000592	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000106	0.000589	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Prednisone—atopic dermatitis	0.000106	0.0054	CbGdCrCtD
Carfilzomib—PSMB2—Disease—CCR5—atopic dermatitis	0.000105	0.000581	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CCR5—atopic dermatitis	0.000105	0.000581	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CCR5—atopic dermatitis	0.000105	0.000581	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CCR5—atopic dermatitis	0.000104	0.000573	CbGpPWpGaD
Carfilzomib—PSMB8—Fluorometholone—Prednisolone—atopic dermatitis	0.000103	0.00527	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Fluocinonide—atopic dermatitis	0.000102	0.00522	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Fluocinonide—atopic dermatitis	0.000102	0.00522	CbGdCrCtD
Carfilzomib—PSMB10—Signaling Pathways—NGF—atopic dermatitis	9.98e-05	0.000552	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NGF—atopic dermatitis	9.93e-05	0.00055	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	9.93e-05	0.00507	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	9.93e-05	0.00507	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—IFNG—atopic dermatitis	9.76e-05	0.00054	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFNG—atopic dermatitis	9.72e-05	0.000538	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CCR5—atopic dermatitis	9.71e-05	0.000537	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CCR5—atopic dermatitis	9.66e-05	0.000535	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—NFKBIA—atopic dermatitis	9.65e-05	0.000534	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—NFKBIA—atopic dermatitis	9.65e-05	0.000534	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—NFKBIA—atopic dermatitis	9.65e-05	0.000534	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—NFKBIA—atopic dermatitis	9.51e-05	0.000526	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL10—atopic dermatitis	9.49e-05	0.000525	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL10—atopic dermatitis	9.49e-05	0.000525	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL10—atopic dermatitis	9.49e-05	0.000525	CbGpPWpGaD
Carfilzomib—PSMB8—Testosterone Propionate—Hydrocortisone—atopic dermatitis	9.45e-05	0.00483	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—CD4—atopic dermatitis	9.43e-05	0.000522	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—atopic dermatitis	9.38e-05	0.000519	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL10—atopic dermatitis	9.35e-05	0.000518	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Methylprednisolone—atopic dermatitis	8.82e-05	0.00451	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—IL1B—atopic dermatitis	8.71e-05	0.000482	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—atopic dermatitis	8.71e-05	0.000482	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CASP8—atopic dermatitis	8.7e-05	0.000482	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CASP8—atopic dermatitis	8.7e-05	0.000482	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CASP8—atopic dermatitis	8.7e-05	0.000482	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Betamethasone—atopic dermatitis	8.68e-05	0.00444	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Dexamethasone—atopic dermatitis	8.68e-05	0.00444	CbGdCrCtD
Carfilzomib—PSMB10—Immune System—IL2—atopic dermatitis	8.68e-05	0.00048	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL1B—atopic dermatitis	8.67e-05	0.00048	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—atopic dermatitis	8.66e-05	0.000479	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2—atopic dermatitis	8.63e-05	0.000478	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CASP8—atopic dermatitis	8.58e-05	0.000475	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Triamcinolone—atopic dermatitis	8.48e-05	0.00433	CbGdCrCtD
Carfilzomib—PSMB5—Metabolism—PPARA—atopic dermatitis	8.44e-05	0.000467	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PPARA—atopic dermatitis	8.44e-05	0.000467	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PPARA—atopic dermatitis	8.44e-05	0.000467	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PPARA—atopic dermatitis	8.32e-05	0.00046	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NFKBIA—atopic dermatitis	8.23e-05	0.000455	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NFKBIA—atopic dermatitis	8.19e-05	0.000453	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCL5—atopic dermatitis	8.17e-05	0.000452	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCL5—atopic dermatitis	8.17e-05	0.000452	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCL5—atopic dermatitis	8.17e-05	0.000452	CbGpPWpGaD
Carfilzomib—PSMB8—Diflorasone—Prednisone—atopic dermatitis	8.05e-05	0.00411	CbGdCrCtD
Carfilzomib—PSMB8—Signaling Pathways—CCL5—atopic dermatitis	8.05e-05	0.000446	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—MAPK8—atopic dermatitis	7.98e-05	0.000442	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—MAPK8—atopic dermatitis	7.95e-05	0.00044	CbGpPWpGaD
Carfilzomib—PSMB8—Dexamethasone—Mometasone—atopic dermatitis	7.92e-05	0.00405	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Mometasone—atopic dermatitis	7.92e-05	0.00405	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Prednisolone—atopic dermatitis	7.86e-05	0.00401	CbGdCrCtD
Carfilzomib—ABCB1—Metabolism—GLB1—atopic dermatitis	7.65e-05	0.000423	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NGF—atopic dermatitis	7.56e-05	0.000419	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NGF—atopic dermatitis	7.56e-05	0.000419	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NGF—atopic dermatitis	7.56e-05	0.000419	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NGF—atopic dermatitis	7.46e-05	0.000413	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	7.4e-05	0.00041	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—atopic dermatitis	7.4e-05	0.000409	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—atopic dermatitis	7.4e-05	0.000409	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—atopic dermatitis	7.4e-05	0.000409	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CCR5—atopic dermatitis	7.36e-05	0.000407	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CCR5—atopic dermatitis	7.36e-05	0.000407	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CCR5—atopic dermatitis	7.36e-05	0.000407	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADSL—atopic dermatitis	7.33e-05	0.000406	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—atopic dermatitis	7.29e-05	0.000404	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CCR5—atopic dermatitis	7.25e-05	0.000401	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—atopic dermatitis	7.15e-05	0.000395	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—atopic dermatitis	7.15e-05	0.000395	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—atopic dermatitis	7.15e-05	0.000395	CbGpPWpGaD
Carfilzomib—PSMB8—Norethindrone—Hydrocortisone—atopic dermatitis	7.08e-05	0.00362	CbGdCrCtD
Carfilzomib—PSMB8—Immune System—CD4—atopic dermatitis	7.04e-05	0.00039	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—atopic dermatitis	6.6e-05	0.000365	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—atopic dermatitis	6.6e-05	0.000365	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—atopic dermatitis	6.6e-05	0.000365	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—atopic dermatitis	6.6e-05	0.000365	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—atopic dermatitis	6.6e-05	0.000365	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—atopic dermatitis	6.6e-05	0.000365	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—atopic dermatitis	6.57e-05	0.000364	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—atopic dermatitis	6.57e-05	0.000364	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—atopic dermatitis	6.57e-05	0.000364	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—atopic dermatitis	6.51e-05	0.00036	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—atopic dermatitis	6.5e-05	0.00036	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—atopic dermatitis	6.48e-05	0.000359	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NFKBIA—atopic dermatitis	6.24e-05	0.000345	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NFKBIA—atopic dermatitis	6.24e-05	0.000345	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NFKBIA—atopic dermatitis	6.24e-05	0.000345	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NFKBIA—atopic dermatitis	6.15e-05	0.00034	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MAPK8—atopic dermatitis	6.05e-05	0.000335	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MAPK8—atopic dermatitis	6.05e-05	0.000335	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MAPK8—atopic dermatitis	6.05e-05	0.000335	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MAPK8—atopic dermatitis	5.97e-05	0.00033	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—atopic dermatitis	5.87e-05	0.000325	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	5.86e-05	0.000324	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—atopic dermatitis	5.84e-05	0.000323	CbGpPWpGaD
Carfilzomib—PSMB8—Levonorgestrel—Hydrocortisone—atopic dermatitis	5.63e-05	0.00288	CbGdCrCtD
Carfilzomib—PSMB10—Signaling Pathways—IL2—atopic dermatitis	5.61e-05	0.00031	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—atopic dermatitis	5.58e-05	0.000309	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	5.3e-05	0.000293	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MAPK8—atopic dermatitis	5.16e-05	0.000286	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MAPK8—atopic dermatitis	5.14e-05	0.000284	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—atopic dermatitis	5.1e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—atopic dermatitis	5.07e-05	0.000281	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Hydrocortisone—atopic dermatitis	5.01e-05	0.00256	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Hydrocortisone—atopic dermatitis	5.01e-05	0.00256	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Methylprednisolone—atopic dermatitis	4.73e-05	0.00242	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Methylprednisolone—atopic dermatitis	4.73e-05	0.00242	CbGdCrCtD
Carfilzomib—PSMB10—Disease—IL6—atopic dermatitis	4.71e-05	0.000261	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—atopic dermatitis	4.69e-05	0.000259	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Dexamethasone—atopic dermatitis	4.66e-05	0.00238	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Betamethasone—atopic dermatitis	4.66e-05	0.00238	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Triamcinolone—atopic dermatitis	4.55e-05	0.00232	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Triamcinolone—atopic dermatitis	4.55e-05	0.00232	CbGdCrCtD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—atopic dermatitis	4.45e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—atopic dermatitis	4.45e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—atopic dermatitis	4.45e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—atopic dermatitis	4.39e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Prednisone—atopic dermatitis	4.32e-05	0.00221	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisone—atopic dermatitis	4.32e-05	0.00221	CbGdCrCtD
Carfilzomib—PSMB1—Signaling Pathways—IL2—atopic dermatitis	4.25e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—atopic dermatitis	4.25e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—atopic dermatitis	4.25e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB8—Dexamethasone—Prednisolone—atopic dermatitis	4.21e-05	0.00215	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Prednisolone—atopic dermatitis	4.21e-05	0.00215	CbGdCrCtD
Carfilzomib—PSMB8—Signaling Pathways—IL2—atopic dermatitis	4.19e-05	0.000232	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MAPK8—atopic dermatitis	3.91e-05	0.000217	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MAPK8—atopic dermatitis	3.91e-05	0.000217	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MAPK8—atopic dermatitis	3.91e-05	0.000217	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—atopic dermatitis	3.86e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—atopic dermatitis	3.86e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—atopic dermatitis	3.86e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MAPK8—atopic dermatitis	3.86e-05	0.000213	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—atopic dermatitis	3.81e-05	0.000211	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—atopic dermatitis	3.57e-05	0.000197	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—atopic dermatitis	3.57e-05	0.000197	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—atopic dermatitis	3.57e-05	0.000197	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—atopic dermatitis	3.52e-05	0.000195	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—atopic dermatitis	3.3e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—atopic dermatitis	3.28e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—atopic dermatitis	2.5e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—atopic dermatitis	2.5e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—atopic dermatitis	2.5e-05	0.000138	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARA—atopic dermatitis	2.48e-05	0.000137	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—atopic dermatitis	2.46e-05	0.000136	CbGpPWpGaD
